Comparative evaluation of Monistat and Mycostatin in the treatment of vulvovaginal candidiasis.
D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000494:pharmacology; D004987:Ethers / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D009761:Nystatin / Q000008:administration & dosage / Q000627:therapeutic use*; D009824:Ointments; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D013607:Tablets
D000935:Antifungal Agents; D001593:Benzyl Compounds; D003276:Contraceptives, Oral; D004987:Ethers; D007093:Imidazoles; D009824:Ointments; D013607:Tablets; D009761:Nystatin